In an interview with CNBC-TV18, Arun Kumar, Vice Chairman and MD, Strides Arcolab said Polymyxin is a small molecule, but currently it is in the shortage list of products. He further said the company will grow 30-35% in the current year.
first published: Jul 1, 2011 12:53 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

